Filing Flows › Oncotelic Therapeutics (OTLC) › Recalls, complaints & regulation
Oncotelic Therapeutics (OTLC): clinical trials
Oncotelic Therapeutics (OTLC) beyond its filings: 2 active clinical trials.
Oncotelic Therapeutics' latest quarter
Oncotelic Therapeutics, Q2 2026: revenue $250K, operating margin -337.4%, net earnings $341K, operating cash flow −$92K. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Oncotelic Therapeutics have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.